Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: New Zealand health tech looks to Malaysia

Leaders from New Zealand’s health technology industry are looking to Malaysia as a strategic investment opportunity to support the country’s rapidly growing healthcare market.

Malaysia’s healthcare sector is among the fastest growing industries in the country. Ambitious growth targets under the government’s Economic Transformation Program (ETP) put healthcare on course to contribute M$50.5 billion (US$12.4 billion) to Gross National Income by 2020, trebling the sector’s contribution over ten years.

Seven New Zealand health technology companies are visiting Malaysia to explore partnership opportunities and will attend this week’s Association of Private Hospitals Malaysia (APHM) International Healthcare Conference and Exhibition in Kuala Lumpur. These companies will share their expertise on how health technology can improve efficiency, enhance patient services and reduce costs.

Simon Hearsey, New Zealand’s Trade Commissioner to Malaysia, says the healthcare sector represents a huge opportunity not just for Malaysian companies but companies that have had success in other parts of the world who are willing to partner and invest to support this growth.

“Health tech has been a booming sector in New Zealand and it has helped the overall sector evolve. New Zealand companies have a long history of successful partnerships here in Malaysia, and I am excited to see how our innovative health tech companies can work with their Malaysian counterparts to develop solutions that will address the unique challenges in the healthcare sector,” he said.

Like many countries across the region, Malaysia is faced with changing patient needs caused by an ageing population and the growing prevalence of chronic disease. The healthcare sector is looking for smart technology solutions to create greater value for both the provider and patient.

A particular area of focus is how to harness big data to provide better patient care. Mark Capill, head of research and development at Orion Health, says hospitals and health authorities are capturing a significant amount of data each day but they need to manage it in a secure and safe way, and more importantly be able to use it effectively.

“Patient data can provide valuable insights that help to improve healthcare across the board. One area of focus for us is how to combine hospital data with social and environmental information about patients to create personalised health care plans. I look forward to discussing how this technology can be used to improve patient care in Malaysia,” he said.

Another company looking to use data in a more effective way is Precept Health, which provides systems to manage patient data, with a focus on critical care. These tools give healthcare professionals reliable access to comprehensive patient records, allowing them to work more efficiently and enabling them to focus on patient care.

Other New Zealand companies in attendance will showcase tools that can streamline hospital data systems, provide better diagnostic information and connect patient records to achieve greater operational efficiency for hospitals.

As technology helps to expand healthcare outside of the traditional hospital setting, Trade Commissioner Simon Hearsey is confident that collaboration will be key to the continued innovation. “New Zealand businesses are born with a global outlook. Through increased collaboration with our partners in Malaysia, we can develop solutions that will have an impact across the healthcare landscape: from hospitals and community clinics to telemedicine and home care,” said Hearsey.

Posted on: 30/07/2018 UTC+08:00


News

Chularat Hospital, which operates 13 clinics and hospitals in Thailand, intends to build the Suvarnabhumi Cancer and Radiologist Center Hospital, which will provide specialised medical services to general patients and counterparties in Samutprakan and nearby provinces.
Thomson Medical Group (TMG), Singapore’s second largest healthcare group, has reported EBITDA of S$23.4 million (US$17.1 million) on the back of total revenue for the first half of the year at S$105.5 million.
Healthcare services group Clearbridge Health has reported revenue of S$1.46 million (US$1.1 million) for the three months ended 30 June 2018. The topline growth is nearly four times the S$0.38 million achieved by the group in Q1 and mainly attributed to recent acquisitions including a medical centre in the Philippines in January and in Singapore and Indonesia in April.
Australian hearing implant manufacturer Cochlear delivered net profit of A$245.8 million, an increase of 10% on FY17, which was within the guidance range of A$240-250 million. Chief executive and president Dig Howitt said, “Cochlear continues to deliver on its objective of delivering consistent revenue and earnings growth over time.
Shareholders of Fortis Healthcare, the country’s second largest private hospital chain, have approved the US$584.1 million acquisition plan by IHH Healthcare, Asia’s largest healthcare company – 99.7% voted in favour of the deal.
Retirement village operator Summerset Group Holdings has announced an underlying profit of NZ$45.2 million (US$29.7 million), an increase of 27%, in line with the profit guidance provided in early July.
Leading fully integrated plasma-based biopharmaceutical company China Biologic Products Holdings has appointed Bing Li as chief executive officer. By assuming the CEO position, Li has moved from an independent director to an executive director of the board. Zhijun Tong, the former acting CEO, will continue to serve as an executive director of the board and president of the company.
Beijing-based paediatric healthcare provider New Century Healthcare has taken a 10.1% stake in Chiron Healthcare. Financial terms have not been disclosed.



Analysis

First you must find a clinic space from which to practice. The good news is that space is available at most hospitals. The bad news is that a 1,200 square-foot clinic space at Mount Elizabeth Hospital currently retails for around S$10 million, or US$7.34 million to secure a space less than half the size of a tennis court. By the time you add fittings, equipment and staff, your relationship with your bank manager will likely be under severe strain.
China’s hospital landscape is rapidly changing as operators and owners respond to shifting policy incentives, an aging population, the opportunity to serve Tier 2 and 3 cities, and shifts in consumer preferences.
Today, more and more people are suffering from serious, incurable, and/or rare illnesses. However, access to information on such conditions has been quite limited, to hospitals or internet surfing. Even though there were communities and organizations serving people with certain illnesses, information was not widely available, due to the general nature of the illnesses.
CR Phoenix Healthcare, China’s largest private hospital group, recently announced plans to restructure Beijing Jingmei Group General Hospital, a flagship hospital managed by CR Phoenix under its investment-operation-transfer (IOT) model.
Severe abuses continue in China's organ transplant system – including the sourcing of organs from prisoners of conscience on a large scale – despite Chinese government assertions of reform, finds a new study by the China Organ Harvest Research Center.
Asia Pacific's transition from a volume- to value-based care model has been highly challenging due to the need for large-scale regulatory changes and lack of a funding. Rising healthcare consumerism, digital health adoption, and the growing influence of medical tourism are setting a foundation for population health management, one form of value-based care that shifts the industry focus from episodic, individualised healthcare approaches to collective action against the cost and burden of disease in a society.
Leaders from New Zealand’s health technology industry are looking to Malaysia as a strategic investment opportunity to support the country’s rapidly growing healthcare market.
Ping An Healthcare and Technology, formerly known as Good Doctor, has signed contracts with nearly 200 large corporations, including Vanke, Greentown, Bank of China, China Telecom, China National Nuclear Power, Evergrande Group and provides services to nearly 1.5 million employees, covering 27 provinces, autonomous regions and municipalities.
my images

Podcasts

HealthInvestor Asia twitter feed